Takeda Pharmaceutical (TAK) Debt Ratio (2018 - 2026)

Takeda Pharmaceutical's Debt Ratio history runs 9 years deep, the most recent figure standing at 0.29 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 8.23% year-over-year to 0.29 in Q1 2026; TTM through Mar 2026 was 0.29, a 8.23% decrease from a year earlier, with the FY2026 full-year figure at 0.29, down 8.23% from the prior year.
• Debt Ratio climbed to 0.29 in Q1 2026 per TAK's latest filing, from 0.28 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.33 in Q1 2022 and bottomed at 0.06 in Q1 2023.
• The 5-year median for Debt Ratio is 0.3 (2023), against an average of 0.27.
• Across the five-year window, Debt Ratio surged 456.04% in 2022 and slumped 81.01% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.29 in 2022, then climbed by 4.14% to 0.3 in 2023, then rose by 3.16% to 0.31 in 2024, then dropped by 11.01% to 0.28 in 2025, then increased by 4.94% to 0.29 in 2026.
• Per Business Quant, the three latest TAK Debt Ratio figures stand at 0.29 (Q1 2026), 0.28 (Q4 2025), and 0.3 (Q3 2025).